Zobrazeno 1 - 10
of 20
pro vyhledávání: ''
Autor:
Rui Xu, Jianjun Wang, Xiaowei Sun, Gang Fang, Chengjing Sun, Yanhua Wang, Xiaolong Zhao, Liming Shao
Publikováno v:
Annals of Hepatology, Vol 19, Iss 5, Pp 535-540 (2020)
Introduction and objectives Hepatocellular carcinoma (HCC) is the second most lethal cancer around the world, with poor survival rate and high metastasis rate in patients. Long noncoding RNAs (lncRNAs) have been reported to modulate the initiation an
Autor:
Hyun Yang Yeo, Kyung Hae Jung, Yongjun Cha, Sun-Young Kim, Moon Ki Choi, Hee Jin Chang, Seung Myung Dong, Ji Yeon Baek
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 1, Pp 146-155 (2019)
Neoplasia (New York, N.Y.)
Neoplasia (New York, N.Y.)
Aberrant promoter methylation plays a vital role in colorectal carcinogenesis. However, its role in treatment responses is unclear, especially for metastatic disease. Here, we investigated the association between promoter methylation and treatment ou
Autor:
Elisa Thomas, Mechthild Krause
Publikováno v:
EBioMedicine, Vol 58, Iss, Pp 102901-(2020)
EBioMedicine
EBioMedicine 58(2020), 102901
EBioMedicine
EBioMedicine 58(2020), 102901
Background Emerging biomarkers from medical imaging or molecular characterization of tumour biopsies open up for combining the two and exploiting their synergy in treatment planning of cancer patients. We generated a paired data set of imaging- and g
Autor:
Faridha Jane Momin, Partha Pratim Medhi, Mouchumee Bhattacharyya, Apurba Kumar Kalita, Jyotiman Nath, Gautam Sarma
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss, Pp 100248-(2020)
Aim The aim is to retrospectively evaluate the clinical outcomes and treatment related toxicities in patients of synchronous esophageal and head & neck cancer when treated with definitive radiotherapy with or without concurrent chemotherapy. Backgrou
Autor:
Sylvain Morinière, Christian Righini, Sarah Atallah, Franck Jegoux, Nicolas Fakhry, Esteban Brenet, Bertrand Baujat, Pierre Philouze, Haitham Mirghani, Patrice Gallet, Antoine Moya-Plana, Benjamin Verillaud, Ludovic de Gabory, Philippe Schultz, Vianney Bastit, Gilles Poissonnet, Chloé Bertolus, Nicolas Bon-Mardion, Olivier Malard, Sébastien Vergez, Jérémie Bettoni, Xavier Dufour, Olivier Mauvais, Maria Lesnik, Diane Evrard, Pierre Ransy, Julian Biau
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2020, ⟨10.1016/j.ejca.2019.12.026⟩
European Journal of Cancer, 2020, ⟨10.1016/j.ejca.2019.12.026⟩
European Journal of Cancer, Elsevier, 2020, ⟨10.1016/j.ejca.2019.12.026⟩
European Journal of Cancer, 2020, ⟨10.1016/j.ejca.2019.12.026⟩
Background Patterns of nodal involvement in adenoid cystic carcinoma (ACC) of the head and neck have not been sufficiently assessed to guide a decision of prophylactic neck dissection (ND). The objective of this study is to analyse the influence of N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aed84f790b5f82d2d4ad1b505077d0e
http://hdl.handle.net/20.500.12278/27865
http://hdl.handle.net/20.500.12278/27865
Autor:
Dae Seog Heo, Miso Kim, Yung-Jue Bang, Chan Young Ock, Young Whan Kim, Young Sik Park, Do Youn Oh, Changhee Park, Bhumsuk Keam, Sun Mi Choi, Tae Min Kim, Soon Ho Yoon, Dong Wan Kim
Publikováno v:
ESMO Open, Vol 4, Iss 6 (2019)
ESMO Open
ESMO Open
Background For the management of immune checkpoint inhibitor (ICI)-induced pneumonitis (ICI-pneumonitis), discontinuation of ICIs and high dose corticosteroid based on grade are generally recommended. The purpose of this study is to describe manageme
Autor:
Martínez-Cuadrón D, Gil C, Serrano J, Rodríguez G, Pérez-Oteyza J, García-Boyero R, Jiménez-Bravo S, Vives S, Vidriales MB, Lavilla E, Pérez-Simón JA, Tormo M, Colorado M, Bergua J, López JA, Herrera P, Hernández-Campo P, Gorrochategui J, Primo D, Rojas JL, Villoria J, Moscardó F, Troconiz I, Linares Gómez M, Martínez-López J, Ballesteros J, Sanz M, Montesinos P, Spanish PETHEMA group
Publikováno v:
LEUKEMIA RESEARCH
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Leukemia Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Dadun. Depósito Académico Digital de la Universidad de Navarra
Consejo Superior de Investigaciones Científicas (CSIC)
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Digital.CSIC. Repositorio Institucional del CSIC
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Leukemia Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Dadun. Depósito Académico Digital de la Universidad de Navarra
Consejo Superior de Investigaciones Científicas (CSIC)
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Digital.CSIC. Repositorio Institucional del CSIC
Complete remission (CR) after induction therapy is the first treatment goal in acute myeloid leukemia (AML) patients and has prognostic impact. Our purpose is to determine the correlation between the observed CR/CRi rate after idarubicin (IDA) and cy
Autor:
Farhad Ravandi
Publikováno v:
Leukemias: Principles and Practice of Therapy
Progress in the treatment of patients with hairy cell leukemia (HCL) has led to a significant change in the natural history of the disease. With current regimens, the majority of patients achieve a complete remission, and their survival curves are si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2414b0dc27e86a7a7f62ad4ebe6a3e5a
https://doi.org/10.1016/b978-0-323-35762-3.00078-0
https://doi.org/10.1016/b978-0-323-35762-3.00078-0
Autor:
J. Mathurin, Jean-Frédéric Blanc, S. Ghazi, Yuk Ting Ma, Daniel H. Palmer, Tim Meyer, Olusola Olusesan Faluyi, Boris Campillo-Gimenez, Julien Edeline, J King
Publikováno v:
European Journal of Cancer
Background No prognostic classification is currently used for patients treated with systemic therapies for Hepatocellular Carcinoma (HCC). Methods We retrospectively analysed data from patients treated with sorafenib for HCC from five centres in Fran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6d919dcba8520ef3c0c03d26f5faec8
Autor:
Pietro Carotenuto, Umberto Cillo, Ian Said-Huntingford, Lorenza Rimassa, Claudia Mescoli, Andrea Lampis, Armando Santoro, Alessandro Zerbi, Matteo Fassan, Chiara Braconi, Massimo Rugge, Michele Ghidini, Maria C. Previdi, Nicola Valeri, Massimo Roncalli, Maya Raj, Francesco Trevisani, Jens C. Hahne, Guido Torzilli, Luciano Cascione
Publikováno v:
European Journal of Cancer
Although biliary tract cancers (BTCs) are known to have an inflammatory component, a detailed characterisation of immune-related transcripts has never been performed. In these studies, nCounter PanCancer Immune Profiling Panel was used to assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90f154936d798bd9cb01133686db503a
https://eprints.gla.ac.uk/188219/1/188219.pdf
https://eprints.gla.ac.uk/188219/1/188219.pdf